EC may propose universal BST ban

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

To ban or not to ban?

The past four years have seen a steady increase in the number of companies that offer direct-to-consumer (DTC) genetic testing services and in the number of such tests for genetic risk factors, including a wide range of diseases and other non-disease-related traits. These companies sell their tests outside the traditional healthcare setting and often do not involve healthcare professionals for ...

متن کامل

BST BioScience Trends

A one-paragraph abs t rac tconsisting of no more than 250 words mustbe included. The abstract should briefly statethe purpose of the study, methods, mainfindings, and conclusions. Abbreviationsmust be kept to a minimum and non-standardabbreviations explained in brackets at firstmention. References should be avoided inthe abstract.

متن کامل

LNG may still be the best oral EC option.

for obesity could possibly have reduced confounding, but it would not have eliminated it, especially since its effect in combination with other risk factors is multiplicative. With regard to possible confounding from other sources, VTE was more frequently diagnosed in women who only completed primary school. Socioeconomic status was thus a determinant of VTE risk, and the possibility that this ...

متن کامل

1 the Bst Case

Recombinant Bovine Somatotropin (rBST) is a milk production enhancer, a product of industrial microbiology. First approved for commercial sale in the United States (U.S.) by the Food and Drug Administration (FDA) in 1994, rBST has been immersed in controversy since the early 1980s. Conflicts among major players with interests in rBST have shaped the product's image and influenced its use. Playe...

متن کامل

Bromoxynil Ban

a potent new luteinising hormone-releasing hormone agonist Zoladex (ICI 118630) in a phase I clinical trial. On progression of disease 26 patients have undergone therapeutic oophorectomy. We present the clinical and endocrinological responses to treatment in 45 assessable patients. The response rate to Zoladex in this series was 31% and the ER status of the primary tumour was predictive of a re...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Nature Biotechnology

سال: 1999

ISSN: 1087-0156,1546-1696

DOI: 10.1038/9781